Serial Number | 79296462 |
Word Mark | TIEFENBACHER |
Filing Date | Wednesday, August 26, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, March 31, 2022 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Medicinal specialities; generic medicines; pharmaceutical, chemical, biological and biochemical products, preparations and reagents, in particular for medical and diagnostic purposes; microorganisms, proteins, polypeptides, nucleotides, nucleic acids, cell-lines and cells, in particular for medical and diagnostic purposes, for investigation and characterisation of diseases, for medical research and development of medicines and for the manufacture of medicines and pharmaceuticals; sanitary preparations for medical purposes; dietetic preparations adapted for medical use; a full line of pharmaceuticals |
Goods and Services | Chemical, biological and biochemical products, preparations and reagents for scientific, research, laboratory and industrial purposes (other than for medical purposes); micro-organisms, proteins, polypeptides, nucleotides, nucleic acids, cell-lines and cells, in particular for scientific, research, laboratory and industrial purposes, other than for medical purposes; pharmaceutical, chemical, biological and biochemical products, preparations and reagents for researching and characterising diseases, for medical research and medicine development and for manufacturing medicines and pharmaceuticals; Chemical reagents for scientific use; biological diagnostic reagents for clinical or medical laboratory use; chemical preparations for general industrial manufacturing; Cells for scientific and research use; nucleic acid for laboratory use; biochemical, namely, polypeptides for in vitro research use; cultures of micro-organisms, other than for medical use; protein for industrial use, nucleotides for scientific and research use; Chemical additives for use in the manufacture of pharmaceuticals |
Goods and Services | Scientific and technological services, consultancy and research, in particular in the field of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for medicine development and for manufacturing medicines and pharmaceuticals; scientific and industrial research and development, in particular in the fields of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for development of medicines and for the manufacture of medicines and pharmaceuticals; investigation and development of medicines, diagnostic and analysis agents and therapy procedures (medical research); pharmaceutical, genealogical, bacteriological, biological, biochemical, chemical, molecular biological and forensic laboratories (other than medical consultancy); scientific experiments and providing scientific expertise in the fields of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for development of medicines and for the manufacture of medicines and pharmaceuticals; providing of technical information relating to generic medicines; services in relation to and advice on product development and quality maintenance; services of a medical and veterinary laboratory, in particular testing of medicines for others, development of new medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Technical consulting in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical research services; pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical drug development services; Medical and scientific research, namely, conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals; conducting clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; design and testing for new product development; chemical laboratories; Scientific and technological services, namely, scientific research, analysis, testing in the fields of pharmaceutical and drug development; scientific investigations for medical purposes; quality control for others; pharmaceutical drug development services; consultation in the private label manufacture and custom manufacture of pharmaceuticals and drugs |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 26, 2020 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 26, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 26, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Alfred E. Tiefenbacher GmbH & Co. KG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 28 - NOT AVAILABLE |
Address | DE |
Event Date | Event Description |
Monday, April 24, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Friday, March 31, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, March 31, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Sunday, April 10, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Thursday, March 31, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Thursday, March 31, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, March 23, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, March 23, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Friday, September 17, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Friday, September 17, 2021 | FINAL REFUSAL E-MAILED |
Friday, September 17, 2021 | FINAL REFUSAL WRITTEN |
Tuesday, July 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, July 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, June 5, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
Sunday, February 14, 2021 | REFUSAL PROCESSED BY IB |
Monday, January 25, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, January 25, 2021 | REFUSAL PROCESSED BY MPU |
Wednesday, January 6, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, January 5, 2021 | NON-FINAL ACTION WRITTEN |
Sunday, December 27, 2020 | ASSIGNED TO EXAMINER |
Friday, October 30, 2020 | APPLICATION FILING RECEIPT MAILED |
Monday, October 26, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, October 22, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |